Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2008
11/26/2008CN100435799C Combination therapy
11/26/2008CN100435798C Preparation of ligustrazine and ligustrazine salt drop pills utilizing nano technology
11/26/2008CN100435797C Oral quick release preparation of indinavir, and preparing method
11/26/2008CN100435796C Cardioprotective delta opioid receptor agonists and methods of using same
11/26/2008CN100435795C Micro-powder dom peridone maleate medicinal composition and its preparing method
11/26/2008CN100435794C Use of 4-[(4-thiazolyl) phenoxl] alkoxy-benzamidine derivatives for treatment of osteoporosis
11/26/2008CN100435793C Medicament, containing effector of glutathione metabolism together with alpha-lipoic acid for use in kidney replacement therapy
11/26/2008CN100435792C Application of butylbenzene phthalein homolog in preparation of medicine for treating cerebral ischemia disease
11/26/2008CN100435791C Solid bicyclic alcohol dispersion
11/26/2008CN100435790C EGCG-zinc complex solid dispersion, its preparation method and application
11/26/2008CN100435789C Flavonoids used as anti-rejection agent
11/26/2008CN100435788C Inhibitor for perioperative blood sugar elevation
11/26/2008CN100435787C Preventive or remedy for intrauterine late embryonic development or pregnancy toxemia
11/26/2008CN100435786C Application of hypericin in preparing RNA virus resisting medicine
11/26/2008CN100435785C Methods and compounds for inhibiting amyloid deposits
11/26/2008CN100435784C Method for preparing inorganic salt nanometer particles containing and packing traditional Chinese medicine and its application
11/26/2008CN100435783C Orally administered composition containing fat soluble ingredient of red sage root
11/26/2008CN100435665C Starch sub types and lipid metabolism
11/25/2008US7456333 Transgenic non-human mammals that reproduce human pathologies of stem cell origins, such as chromosomal anomalies associated with chronic myeloid leukemia, B-cell acute lymphoblastic leukemia, T-cell acute or lymphoblastic leukemia, or with the migration of hematopoietic or embryonic stem calls.
11/25/2008US7456317 Substituted phenethylamines with serotoninergic and/or norepinephrinergic activity
11/25/2008US7456312 making gabapentin tannate to treat central nervous system disorders by reacting gabapentin and tannic acid; used in sustained release applications and to improve certain organoleptic properties such as taste
11/25/2008US7456302 Method for producing pentacyclic taxans
11/25/2008US7456297 crystalline polymorphic dosage forms of anticholesterol agents; statins; small particle size distribution
11/25/2008US7456296 Reacting perindopril in a solvent selected from N,N-dimethylformamide, dimethoxymethane, 2,2-dimethoxypropane and 1,2-dimethoxyethane with tert-butylamine, crystallization; stereospecific
11/25/2008US7456294 Hairpin polyamide
11/25/2008US7456293 Substituted carboxylic acid derivatives for the treatment of diabetes and lipid disorders, their preparation and use
11/25/2008US7456291 Use of a vitamin combination for the treatment of primary headaches
11/25/2008US7456288 Heterocyclic compounds and methods of making and using thereof
11/25/2008US7456283 an N-phenyl-4-(4-methyl-piperazin-1-ylmethyl)-benzamide claimed intermediate easily prepared by amidation of the aniline and the benzoic acid; reaction with a 2-aminopyrimidine to produce antitumor tyrosine kinase inhibitor
11/25/2008US7456278 Lactams substituted by cyclic succinates as inhibitors of Aβ protein production
11/25/2008US7456275 Endcapped block polymers including ethylene oxide-propylene oxide, glycolic acid-lactic acid, or ethylene oxide-lactic or glycolic acid; low viscosity allows easy injection; capable of room temperature distribution; extended analgesic effectiveness; nontoxic antiarthritic agents; tissue repair
11/25/2008US7456267 Anticarcinogenic agents; nervous system disorders, urogenital disorders; improved biocompatibility
11/25/2008US7456265 Carriers for cosmetics, pharmaceuticals, and veterinary products providing timed releasing of active ingredients
11/25/2008US7456225 Liver protection compounds of the cyclohexenone type from Antrodia camphorata
11/25/2008US7456224 Memantine derivatives (5 - 20 mg per day); methylaspartic receptor antagonist; Pervasive Developmental Disorders (PDD); sensory integration problems, verbal and non-verbal communication, social interactions, and leisure or play activities; side effect reduction
11/25/2008US7456223 Topically applying directly to the skin overlying accessible muscles of mastication for absorption through the skin a therapeutically effective amount of a cyclobenzaprine and a nonsteroidal antiinflammatory agent ketoprofen
11/25/2008US7456222 Anti tubercular drug: compositions and methods
11/25/2008US7456221 Prodrugs of excitatory amino acids
11/25/2008US7456220 Immunodulatory compositions and methods of use thereof
11/25/2008US7456219 Polymorphs of suberoylanilide hydroxamic acid
11/25/2008US7456218 3-(4-{[4'-(benzyloxy)-2',6'-dimethylbiphenyl-3-yl]methoxy}-2-fluorophenyl)propanoic acid; superior GPR40 receptor function modulating action, can be used as an insulin secretagogue, an agent for the prophylaxis or treatment of diabetes
11/25/2008US7456217 Administering N-(2,6-Dichlorobenzoyl)-4-(2,6-dimethoxy-4-methoxymethylphenyl)-L-phenylalanine ethyl ester for therapy of multiple sclerosis
11/25/2008US7456216 Methods for the preparation and formulation of l-carnitine valproate salts
11/25/2008US7456215 Pharmaceutical gallium compositions and methods
11/25/2008US7456214 Cancer; for selectively destroying tumor vasculature; inhibit tubulin polymerization; selectively reducing blood flow to at least a portion of a neoplastic region; 3-(3',4',5'-Trimethoxybenzoyl)-6-hydroxy-7-methoxy-2H-chromene
11/25/2008US7456213 PEG-poly(ortho ester) graft copolymers and pharmaceutical compositions
11/25/2008US7456212 Storage stable cyclic ketone peroxide compositions
11/25/2008US7456211 Enzyme inhibitors as bactericides for infections and as enzyme inhibitors
11/25/2008US7456210 Benzyloxy derivatives
11/25/2008US7456209 IAP binding compounds
11/25/2008US7456208 CCK-1 receptor modulators
11/25/2008US7456207 Vaginal pharmaceutical compositions and methods for preparing them
11/25/2008US7456206 Biaryl heterocyclic compounds and methods of making and using the same
11/25/2008US7456205 Non-insulin dependent diabetes; 7-[2-(5-methyl-2-phenyl-4-oxazole)ethoxyl]-2-oxo-2H-1-benzopyran-3-carboxylic acid methyl ester; insulin-sensitizing activities
11/25/2008US7456204 Cyclohexylglycine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
11/25/2008US7456203 for treatment/prevention of chronic obstructive pulmonary disease, chronic bronchitis, irritable bowel syndrome, and urinary incontinence
11/25/2008US7456202 Marked maleimide compounds, method for preparing same and use thereof for marking macromolecules
11/25/2008US7456201 Such as N-{5-[1-(4-tert-butylphenyl)-3-pyridin-2-yl-1H-pyrazol-5-yl]pentanoyl}tyrosinamide; useful for the treatment of mammalian infertility
11/25/2008US7456200 Compounds
11/25/2008US7456199 Bronchodilators; treating chronic obstructive pulmonary disease or asthma; long duration of action; reduced side effects, such as dry-mouth and constipation; e.g. biphenyl-2-ylcarbamic acid 1-(2-(4-[(4-hydroxybenzylamino)methyl]phenylcarbamoyl)ethyl)piperidin-4-yl ester
11/25/2008US7456198 Useful in the treatment of chronic and acute pain.
11/25/2008US7456196 Alzheimer's disease; antihistamine; attention deficit disorder; hyperactivity; bipolar disorder; cognition activators; psychological disorder; anticancer agent; antidepressants; antiepileptic agents; gastrointestinal disorder; analgesics; 6-{2-[(2R)-2-methyl-1-pyrrolidinyl]ethyl}-2-(3-pyridinyl)quinoline
11/25/2008US7456195 Phenylglycinamide and pyridylglycinamide derivatives useful as anticoagulants
11/25/2008US7456194 Imidazo-fused oxazolo [4,5-b]pyridine and imidazo-fused thiazolo[4,5-b]pyridine based tricyclic compounds and pharmaceutical compositions comprising same
11/25/2008US7456193 Disorders of GABAergic transmission associated with GABAA receptor subtypes, such as anxiety, sleep disorders, epilepsy; 1,6-dimethyl-3-(pyridin-4-yl)-1,9-dihydro-2H-pyrido[2,3-b]indol-2-one
11/25/2008US7456192 3β-amino azabicyclooctane heteroaromatic amid derivatives preparation method and therapeutic uses thereof
11/25/2008US7456191 N-Aryl-sulfoximine-substituted pyrimidines as CDK-and/or VEGF inhibitors, their production and use as pharmaceutical agents
11/25/2008US7456190 autoimmune disease; antiinflammatory agents; bone disorders; central nervous system disorders; cardiovascular disorders; Alzheimer's disease; antihistamines; antiallergens
11/25/2008US7456189 For example, (R)-4-(1-Phenylethylamino)-6-[1-(tert-butyloxycarbonyl)piperidin-4-yloxy]-7-methoxy-quinazoline and (R)-4-(1-Phenylethylamino)-6-(piperidin-4-yloxy)-7-methoxyquinazoline dihydrochloride
11/25/2008US7456188 Bone disorders; cardiovascular diseases; hypercholesterolemia; hypertriglyceridemia; vasomotor disorders; urogenital disorders; prostatic hypertrophy; endometrial hyperplasia; cancer and central nervous system disorders, such as, neurodegenerative disorders
11/25/2008US7456187 Cardiac arrythmias; 5-Phenyl-N-(pyridin-2-ylmethyl)furo[2,3-d]pyrimidin-4-amine
11/25/2008US7456186 Diphenylimidazopyrimidines as inhibitors of β-secretase
11/25/2008US7456185 2-amino-6-phenoxy-substituted quinazoline derivatives; treating arthritis, Crohn's disease, Alzeihmer's disease, adult respiratory distress syndrome, chronic obstructive pulmonary disease, asthma, stroke, sepsis, myocardial infarction, and spondylitis
11/25/2008US7456184 Agonist or antgonist and binders and inversion of agonist
11/25/2008US7456183 Melanocortin-4 receptor agonists; obesity, type II diabetes; such as N-(2-(2-(2,4-dichlorophenyl)ethyl)-1-oxo-2,3-dihydro-1H-isoindol-5-yl) -3-methyl-N'-(2,6,6-trimethylbicyclo(3.1.1)hept-3yl)piperazine-1-carboximidamide
11/25/2008US7456182 Phenylpiperazines
11/25/2008US7456181 Aripiprazole crystalline forms
11/25/2008US7456180 Piperazine derivatives and their use as therapeutic agents
11/25/2008US7456179 Administering 3-aminopyridine-2-carboxaldehyde thiosemicarbazone for therapy of coronary artery bypass graft surgery, global cerebral ischemia, focal cerebral infarction, cerebral hemorrhage, hemorrhage infarction, hypertensive hemorrhage, intracranial vascular hemorrhage, subarachnoid hemorrhage
11/25/2008US7456178 Compounds, methods and pharmaceutical compositions for inhibiting PARP
11/25/2008US7456177 Heteroaryl fused azapolycyclic compounds which bind to neuronal nicotinic acetylcholine specific receptor sites, and which are useful in modulating cholinergic function, for for reducing nicotine addiction or aiding in the cessation or lessening of tobacco use in a mammal, therapy
11/25/2008US7456176 Benzotriazine inhibitors of kinases
11/25/2008US7456175 For treatment and/or prevention of diseases which are associated with the modulation of H3 receptors; treatment of obesity; N-[2-(4-ethyl-piperazin-1-yl)-pyridin-4-yl]-propionamide, 1-[2-(4-ethyl-piperazin-1-yl)-pyridin-4-yl]-3-propyl-urea
11/25/2008US7456174 5-aminoindole derivatives as H3 inverse agonists
11/25/2008US7456173 Compositions comprising zopiclone derivatives and methods of making and using the same
11/25/2008US7456172 Succinoylamino benzodiazepines as inhibitors of Aβ protein production
11/25/2008US7456171 Nicotinic ligands; treatment of nervous system disorders, neurodegenerative disorders, psychological disorders, and tobacco, drug and alcohol withdrawal symptoms
11/25/2008US7456170 Triazolobenzodiazepines and their use as vasopressin antagonists
11/25/2008US7456169 Heterocyclic kinase inhibitors
11/25/2008US7456168 2-(pyridin-2-ylamino)-pyrido[2,3, d]pyrimidin-7-ones
11/25/2008US7456167 Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
11/25/2008US7456166 Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
11/25/2008US7456165 Activity against hepatitis C virus; for example, 13-cyclohexyl-6-(1H-tetrazol-5-yl)-7H-indolo[2,1-a][2]benzazepine-10-carboxylic acid, methyl ester
11/25/2008US7456164 Useful for treatment of H3-related diseases such as neurologic disorders, or inflammatory, respiratory and allergic diseases, disorders and conditions; for example, 4-[4-(1-isopropylpiperidin-4-yloxy)phenyl]tetrahydropyran-4-carbonitrile; well absorbed from gastrointestinal tract, metabolically stable
11/25/2008US7456163 Macrocycles useful in the treatment of alzheimer's disease
11/25/2008US7456162 Benzofuran derivatives, their production and use
11/25/2008US7456161 Use of DHEA and DHEA-sulfate for the treatment of chronic obstructive pulmonary disease
11/25/2008US7456160 Sustained release; injection of fulvestrant; using 7 alpha -[9-(4,4,5,5,5-pentafluoropentylsulphinyl)nonyl]oestra-1,3,5(10)-triene-3,17 beta -diol to treat hormonal dependent benign or malignant disease of the breast or reproductive tract
11/25/2008US7456159 For delivering therapeutically effective amount of a drug that includes a parent drug and a prodrug; for delivering steroids
11/25/2008US7456158 4-dedimethylaminotetracycline derivatives
1 ... 2982 2983 2984 2985 2986 2987 2988 2989 2990 2991 2992 2993 2994 2995 2996 2997 2998 2999 3000 3001 3002 ... 7860